Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a loss-making company: Sales comps and Analyst consensus.
ACCE opinionHuntsman Corporation Common Stock (HUN)
Fair value (2 models)
Not available
ACCE price target
$9.00
Rating
Not rated
Horizon
12 months
ACCE price target published on 12 Oct 2026, 00:00 CEST.
Price used: $8.80 at the close on 23 Oct 2026, 22:00 CEST.
Models: Analyst consensus and Sales comps.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
41
out of 100
Analysts
13% buy
15 covering
P/E
0.0x
forward 53.5x
1-year return
+0.6%
Dividend yield
6.23%
Huntsman Corporation Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Huntsman makes polyurethane systems, MDI and performance additives, and its Advanced Materials and Polyurethanes segments sell into construction, automotive and appliance insulation. The case for a closer look rests on revenue growing 14.1% while the business is still near breakeven, with a 1.7% operating margin and a 13.5% gross margin, so any recovery in pricing or volumes would drop through to earnings quickly. The forward P/E of 53.5 against a trailing P/E of zero says the market is paying for that recovery rather than current profits, and the ROE of -3.8% shows the equity is not yet earning its cost. The score of 41/100 and the absence of index membership point to a stock the screens do not favour, so the work needed is to test whether margin repair is credible within the next few reporting periods. Whether the 14.1% growth is volume-led or price-led, and how much of it survives a normal chemical cycle, is the first question to answer.
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
high
Negative return on equity
ROE is -3.8% and net margin -3.0%, so the company is losing money on shareholder capital. Quality score is 22/100. Trailing P/E is 0.0 because earnings are negative.
moderate
Elevated short interest
Short interest is 8.1% of float. Forward P/E of 53.5 is well above trailing earnings, so the market is pricing in a sharp recovery that has not yet shown up.
moderate
Long-term revenue decline
Five-year revenue CAGR is -1.1% despite recent 14.1% year-on-year growth, which suggests the recent rebound may be cyclical rather than structural.
AI research notes
AI-assisted·How I use AIWritten Oct 13, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Free cash flow over the last twelve months reached $116M, and the stock's free cash flow yield is 8.1%.
Analysts' mean price target of $10.62 sits 31.5% above the $8.07 share price.
Revenue grew 14.1% year over year in the latest quarter, a sharp reversal from its five-year average decline.
Why it could disappoint
The company lost money on every dollar of sales, with a net margin of -3.0% and a return on equity of -3.8%.
Latest earnings per share came in at -0.20 against 0.06 expected, a surprise of -433.3%.
Only 2 of 14 analysts rate the stock Buy or Strong Buy, and the forward P/E stands at 53.5x.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Nov 2, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where HUN's valuation models land
Price
$8.80
Model fair valueConfidence: low
about $34.13
Model
Fair value
Upside
Analyst consensus
Sales comps
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores